The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction
Abstract
We reported aldosterone as a novel adipocyte-derived factor that regulates vascular function. We aimed to investigate molecular mechanisms, signaling pathways, and functional significance of adipocyte-derived aldosterone and to test whether adipocyte-derived aldosterone is increased in diabetes mellitus–associated obesity, which contributes to vascular dysfunction. Studies were performed in the 3T3-L1 adipocyte cell line and mature adipocytes isolated from human and mouse (C57BL/6J) adipose tissue. Mesenteric arteries with and without perivascular fat and mature adipocytes were obtained from obese diabetic db/db and control db/+ mice. Aldosterone synthase (CYP11B2; mRNA and protein) was detected in 3T3-L1 and mature adipocytes, which secrete aldosterone basally and in response to angiotensin II (Ang II). In 3T3-L1 adipocytes, Ang II stimulation increased aldosterone secretion and CYP11B2 expression. Ang II effects were blunted by an Ang II type 1 receptor antagonist (candesartan) and inhibitors of calcineurin (cyclosporine A and FK506) and nuclear factor of activated T-cells (VIVIT). FAD286 (aldosterone synthase inhibitor) blunted adipocyte differentiation. In candesartan-treated db/db mice (1 mg/kg per day, 4 weeks) increased plasma aldosterone, CYP11B2 expression, and aldosterone secretion were reduced. Acetylcholine-induced relaxation in db/db mesenteric arteries containing perivascular fat was improved by eplerenone (mineralocorticoid receptor antagonist) without effect in db/+ mice. Adipocytes possess aldosterone synthase and produce aldosterone in an Ang II/Ang II type 1 receptor/calcineurin/nuclear factor of activated T-cells–dependent manner. Functionally adipocyte-derived aldosterone regulates adipocyte differentiation and vascular function in an autocrine and paracrine manner, respectively. These novel findings identify adipocytes as a putative link between aldosterone and vascular dysfunction in diabetes mellitus–associated obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, the increased aldosterone production by adipocytes in obesity was shown to contribute to the vascular changes associated with this condition (54).”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
In the citing paper
“For instance, adipocyte-derived aldosterone has emerged as a new paradigm in linking obesity with vascular disease (54).”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
In the citing paper
“Moreover, this study revealed that adipocyte-derived aldosterone regulates vascular function in a paracrine manner.”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
In the citing paper
“Adipocytes were found to possess the components necessary for aldosterone synthesis.”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
Citations
Cites
Greenstein, A. S., Khavandi, K., Withers, S., Sonoyama, K., Clancy, O., Jeziorska, M., Laing, I., Yates, A. P., Pemberton, P. W., Malik, R. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.821181 · Cited by 616
Interaction of calcineurin with substrates and targeting proteins
Li, H., Rao, A., & Hogan, P. G. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.09.011 · Cited by 381
Guo, C., Ricchiuti, V., Lian, B. Q., Yao, T. M., Coutinho, P., Romero, J. R., Li, J., Williams, G. H., & Adler, G. K. (2008) · Circulation · doi:10.1161/circulationaha.107.748640 · Cited by 342
Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis
Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M.-C. (2007) · The FASEB Journal · doi:10.1096/fj.06-7970com · Cited by 337
The secretory function of adipocytes in the physiology of white adipose tissue
Wang, P., Mariman, E., Renes, J., & Keijer, J. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21386 · Cited by 318
Enhanced Aldosterone Signaling in the Early Nephropathy of Rats with Metabolic Syndrome
Nagase, M., Yoshida, S., Shibata, S., Nagase, T., Gotoda, T., Ando, K., & Fujita, T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080944 · Cited by 247
Hirata, A., Maeda, N., Hiuge, A., Hibuse, T., Fujita, K., Okada, T., Kihara, S., Funahashi, T., & Shimomura, I. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp191 · Cited by 241
Adipogenic and lipolytic effects of chronic glucocorticoid exposure
Campbell, J. E., Peckett, A. J., D'souza, A. M., Hawke, T. J., & Riddell, M. C. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00045.2010 · Cited by 228
Body Mass Index Predicts Aldosterone Production in Normotensive Adults on a High-Salt Diet
Bentley–Lewis, R., Adler, G. K., Perlstein, T. S., Seely, E. W., Hopkins, P. N., Williams, G. H., & Garg, R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1088 · Cited by 213
Ketonen, J., Jin, S., Martonen, E., & Mervaala, E. M. A. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0661 · Cited by 209
Cited by
Sorted by citations
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889
RetractedPacker, M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.509 · Cited by 656
Effects of Exercise to Improve Cardiovascular Health
Pinckard, K. M., Baskin, K. K., & Stanford, K. I. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00069 · Cited by 517
Obesity and Cardiometabolic Risk Factors: From Childhood to Adulthood
Drożdż, D., Pitti, J. Á., Wójcik, M., Borghi, C., Gabbianelli, R., Mazur, A., Herceg-Čavrak, V., López‐Valcárcel, B. G., Brzeziński, M., Lurbe, E., et al. (2021) · Nutrients · doi:10.3390/nu13114176 · Cited by 441
Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications
Harvey, A., Montezano, A. C. I., Alves-Lopes, R., Rios, F. J. O., & Touyz, R. M. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.070 · Cited by 385
Self-citationHuby, A.-C., Antonova, G., Groenendyk, J., Gomez-Sanchez, C. E., Bollag, W. B., Filosa, J. A., & de Chantemèle, E. J. B. (2015) · Circulation · doi:10.1161/circulationaha.115.018226 · Cited by 376
Senni, M., Paulus, W. J., Gavazzi, A., Fraser, A. G., Dı́ez, J., Solomon, S. D., Smiseth, O. A., Guazzi, M., Lam, C. S. P., Maggioni, A. P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu204 · Cited by 352
Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome
Legeay, S., Rodier, M., Fillon, L., Faure, S., & Clere, N. (2015) · Nutrients · doi:10.3390/nu7075230 · Cited by 358
Jaisser, F., & Farman, N. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.011106 · Cited by 348
Mechanistic Links Between Obesity, Diabetes, and Blood Pressure: Role of Perivascular Adipose Tissue
Saxton, S. N., Clark, B., Withers, S., Eringa, E. C., & Heagerty, A. M. (2019) · Physiological Reviews · doi:10.1152/physrev.00034.2018 · Cited by 290
Montezano, A. C. I., & Touyz, R. M. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5302 · Cited by 280
Self-citationAldosterone, Inflammation, Immune System, and Hypertension
Ferreira, N. S., Tostes, R. C., Paradis, P., & Schiffrin, E. L. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa137 · Cited by 268
Perivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword
Qi, X.-Y., Qu, S.-L., Xiong, W., Rom, O., Chang, L., & Jiang, Z. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0777-x · Cited by 239
The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans
UNDERWOOD, P. C., & Adler, G. K. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0323-2 · Cited by 219
The influence of perivascular adipose tissue on vascular homeostasis
Szasz, T., Bomfim, G. F., & Webb (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s33760 · Cited by 205
Endothelial Dysfunction, Obesity and Insulin Resistance
Prieto, D., Contreras, C., & Sánchez, A. (2014) · Current Vascular Pharmacology · doi:10.2174/1570161112666140423221008 · Cited by 191
The Role of the Renin-Angiotensin-Aldosterone System in Obesity-Related Renal Diseases
Rüster, C., & Wolf, G. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.12.002 · Cited by 192
Packer, M., Lam, C. S. P., Lund, L. H., Maurer, M. S., & Borlaug, B. A. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1902 · Cited by 185
The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction
Packer, M. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.06.055 · Cited by 213
Vascular Actions of Aldosterone
Briet, M. B., & Schiffrin, E. L. (2012) · Journal of Vascular Research · doi:10.1159/000345243 · Cited by 180
The metabolic syndrome and chronic kidney disease
Zhang, X., & Lerman, L. O. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.004 · Cited by 185
Obesity-Related Heart Failure With a Preserved Ejection Fraction
Packer, M., & Kitzman, D. W. (2018) · JACC: Heart Failure · doi:10.1016/j.jchf.2018.01.009 · Cited by 172
Huby, A.-C., Otvos, L. J., & de Chantemèle, E. J. B. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06642 · Cited by 168
The Renin Angiotensin Aldosterone System in Obesity and Hypertension
Cabandugama, P. K., Gardner, M. J., & Sowers, J. R. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.08.009 · Cited by 168
Schütten, M. T. J., Houben, A. J. H. M., de Leeuw, P. W., & Stehouwer, C. D. A. (2017) · Physiology · doi:10.1152/physiol.00037.2016 · Cited by 172
The Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases
Izzo, C., Vitillo, P., Pietro, P. D., Visco, V., Strianese, A., Virtuoso, N., Ciccarelli, M., Galasso, G., Carrizzo, A., & Vecchione, C. (2021) · Life · doi:10.3390/life11010060 · Cited by 177
New concepts in white adipose tissue physiology
de Proença, A. R. G., Sertié, R. A. L., de Oliveira, A. C., Campaãa, A. B., Caminhotto, R. D. O., Chimin, P., & Lima, F. B. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20132911 · Cited by 167
Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis
Rahmouni, K. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.00920 · Cited by 150
Hypertension Related to Obesity: Pathogenesis, Characteristics and Factors for Control
Meouchy, P., Wahoud, M., Allam, S., Chedid, R., Karam, W., & Karam, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012305 · Cited by 176
Obesity and cardiovascular disease in women
Manrique‐Acevedo, C., Chinnakotla, B., Padilla, J., Martinez‐Lemus, L. A., & Gozal, D. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0548-0 · Cited by 154
Choi, M., Kim, Y., Kwon, E., Ryoo, J. Y., Kim, S. R., & Jung, U. J. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515000100 · Cited by 139
Whaley‐Connell, A. T., & Sowers, J. R. (2017) · Kidney International · doi:10.1016/j.kint.2016.12.034 · Cited by 138
Steroid biosynthesis in adipose tissue
Li, J., Papadopoulos, V., & Vihma, V. (2015) · Steroids · doi:10.1016/j.steroids.2015.03.016 · Cited by 130
Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities
Vyas, V. S., & Lambiase, P. D. (2019) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2018.76.2 · Cited by 137
Regional Adiposity and Heart Failure with Preserved Ejection Fraction
Rao, V. N., Fudim, M., Mentz, R. J., Michos, E. D., & Felker, G. M. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1956 · Cited by 131
Chatterjee, T. K., Aronow, B. J., Tong, W. S., Manka, D. R., Tang, Y., Bogdanov, V. Y., Unruh, D. J., Blomkalns, A. L., Piegore, M., Weintraub, D. S., et al. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00042.2013 · Cited by 115
Urbanet, R., Nguyen Dinh Cat, A., Feraco, A., Venteclef, N., El Mogrhabi, S., Sierra-Ramos, C., Alvarez de la Rosa, D., Adler, G. K., Quilliot, D., Rossignol, P., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04981 · Cited by 114
Self-citationChemerin Regulates Crosstalk Between Adipocytes and Vascular Cells Through Nox
Neves, K. B., Nguyen Dinh Cat, A., Lopes, R. A. M., Rios, F. J., Anagnostopoulou, A., Lobato, N. S., de Oliveira, A. M., Tostes, R. C., Montezano, A. C., & Touyz, R. M. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05616 · Cited by 113
Self-citationThe Ubiquitous Mineralocorticoid Receptor: Clinical Implications
Hawkins, U. A., Gómez-Sánchez, E. P., Gomez-Sanchez, C. M., & Gómez-Sánchez, C. E. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0297-0 · Cited by 117
Self-citationRegulation and Functions of the Renin‐Angiotensin System in White and Brown Adipose Tissue
Pahlavani, M., Kalupahana, N. S., Ramalingam, L., & Moustaïd‐Moussa, N. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160031 · Cited by 111
High glucose increases the formation and pro-oxidative activity of endothelial microparticles
Burger, D. E., Turner, M., Xiao, F., Munkonda, M. N., Akbari, S., & Burns, K. D. (2017) · Diabetologia · doi:10.1007/s00125-017-4331-2 · Cited by 110
Self-citationHyperaldosteronism as a Common Cause of Resistant Hypertension
Calhoun, D. A. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-042711-135929 · Cited by 108
The Role of Obesity-Induced Perivascular Adipose Tissue (PVAT) Dysfunction in Vascular Homeostasis
Stanek, A., Brożyna-Tkaczyk, K., & Myśliński, W. (2021) · Nutrients · doi:10.3390/nu13113843 · Cited by 107
Hypertension in Metabolic Syndrome: Vascular Pathophysiology
Mendizábal, Y., Llorens, S., & Nava, E. (2013) · International Journal of Hypertension · doi:10.1155/2013/230868 · Cited by 107
Packer, M. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13229 · Cited by 105
The Effects of Obesity on the Cerebral Vasculature
Dorrance, A. M., Matin, N., & Pires, P. W. (2014) · Current Vascular Pharmacology · doi:10.2174/1570161112666140423222411 · Cited by 97
Adipocytes, aldosterone and obesity-related hypertension
Cat, A. N. D., Friederich‐Persson, M., White, A. D., & Touyz, R. M. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0025 · Cited by 94
Self-citationRoles of Perivascular Adipose Tissue in Hypertension and Atherosclerosis
Hu, H.-J., Garcia-Barrio, M. T., Jiang, Z., Chen, Y. E., & Chang, L. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8103 · Cited by 96
De Novo Synthesis of Steroids and Oxysterols in Adipocytes
Li, J., Daly, E., Campioli, E., Wabitsch, M., & Papadopoulos, V. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534172 · Cited by 95
Renal Nerves and Long‐Term Control of Arterial Pressure
Osborn, J. W., & Foss, J. D. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c150047 · Cited by 93
Srinivasa, S., Fitch, K. V., Wong, K., Torriani, M., Mayhew, C., Stanley, T. L., Lo, J., Adler, G. K., & Grinspoon, S. K. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1461 · Cited by 93
A Nephrologist Perspective on Obesity: From Kidney Injury to Clinical Management
García-Carro, C., Vergara, A., Bermejo, S., Azancot, M. A., Sellarés, J., & Soler, M. J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655871 · Cited by 91
Akoumianakis, I., Tarun, A., & Antoniades, C. A. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13666 · Cited by 91
Circulating Aldosterone and Natriuretic Peptides in the General Community
Buglioni, A., Cannone, V., Cataliotti, A., Sangaralingham, S. J., Heublein, D. M., Scott, C. G., Bailey, K. R., Rodeheffer, R. J., Dessı̀-Fulgheri, P., Sarzani, R., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03936 · Cited by 85
Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism
Karashima, S., Yoneda, T., Kometani, M., Ohe, M., Mori, S., Sawamura, T., Furukawa, K., Seta, T., Yamagishi, M., & Takeda, Y. (2015) · Hypertension Research · doi:10.1038/hr.2015.129 · Cited by 85
The regulation of aldosterone secretion by leptin
Faulkner, J., Bruder-Nascimento, T. B., & de Chantemèle, E. J. B. (2017) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000384 · Cited by 85
Mitochondrial oxidative stress in obesity: role of the mineralocorticoid receptor
Lefranc, C., Friederich‐Persson, M., Palacios, R., & Cat, A. N. D. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0163 · Cited by 80
Burger, D. E., Turner, M., Munkonda, M. N., & Touyz, R. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5047954 · Cited by 73
Self-citationUpdated survey of the steroid-converting enzymes in human adipose tissues
Tchernof, A., Mansour, M. F., Pelletier, M., Boulet, M.-M., Nadeau, M., & Luu-The, V. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.011 · Cited by 73
Kidney and epigenetic mechanisms of salt-sensitive hypertension
Kawarazaki, W., & Fujita, T. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00399-2 · Cited by 73
Obesity and Insulin Resistance in Resistant Hypertension: Implications for the Kidney
Rao, A., Pandya, V., & Whaley‐Connell, A. T. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.12.004 · Cited by 78
Takenaka, T., Kobori, H., Miyazaki, T., Suzuki, H., Nishiyama, A., Ishii, N., Yamashita, M., & Hayashi, M. (2018) · Acta Physiologica · doi:10.1111/apha.13190 · Cited by 72
Perivascular adipose tissue: Fine-tuner of vascular redox status and inflammation
Cheng, C. K., Ding, H., Jiang, M., Yin, H., Gollasch, M., & Huang, Y. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102683 · Cited by 72
Marzolla, V., Armani, A., Feraco, A., Martino, M. U. D., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.001 · Cited by 75
Lefranc, C., Friederich‐Persson, M., Braud, L., Palacios, R., Karlsson, S., Boujardine, N., Motterlini, R., Jaisser, F., & Cat, A. N. D. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.11873 · Cited by 72
Ferreira, N. S., Bruder-Nascimento, T. B., Pereira, C. A., Zanotto, C. Z., Prado, D. D. S., da Silva, J. F., Rassi, D. M., Foss‐Freitas, M. C., Alves-Filho, J. C., Carlos, D., et al. (2019) · Cells · doi:10.3390/cells8121595 · Cited by 70
Atlas of tissue renin-angiotensin-aldosterone system in human: A transcriptomic meta-analysis
Nehme, A., Cerutti, C., Dhaouadi, N., Gustin, M., Courand, P., Zibara, K., & Bricca, G. (2015) · Scientific Reports · doi:10.1038/srep10035 · Cited by 69
Lastra, G., & Manrique, C. M. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0010 · Cited by 70
Genomic and rapid effects of aldosterone: what we know and do not know thus far
Hermidorff, M. M., de Assis, L. V. M., & Isoldi, M. C. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9591-2 · Cited by 71
Bariatric Surgery and Hypertension
Owen, J., Yazdi, F., & Reisin, E. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx112 · Cited by 70
Exercise Training and Cardiometabolic Diseases: Focus on the Vascular System
Roque, F., Hernanz, R., Salaices, M., & Briones, A. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0336-5 · Cited by 69
Self-citationThe Role of Aldosterone in OSA and OSA-Related Hypertension
Wang, Y., Li, C. X., Lin, Y. N., Zhang, L. Y., Li, S. Q., Zhang, L., Yan, Y. R., Lu, F., Li, N., & Li, Q. Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.801689 · Cited by 65
Adipose Tissue and Adrenal Glands: Novel Pathophysiological Mechanisms and Clinical Applications
Kargi, A. Y., & Iacobellis, G. (2014) · International Journal of Endocrinology · doi:10.1155/2014/614074 · Cited by 63
Glucocorticoids and gut bacteria: “The GALF Hypothesis” in the metagenomic era
Morris, D. J., & Ridlon, J. M. (2017) · Steroids · doi:10.1016/j.steroids.2017.06.002 · Cited by 63
Savarese, G., Lindberg, F., Filippatos, G. S., Butler, J., & Anker, S. D. (2023) · Diabetologia · doi:10.1007/s00125-023-06031-1 · Cited by 64
Cortisol dysregulation in obesity-related metabolic disorders
Baudrand, R. F., & Vaidya, A. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000152 · Cited by 64
Cat, A. N. D., Antunes, T. T., Callera, G. E., Sánchez, A., Tsiropoulou, S., Dulak-Lis, M. G., Anagnostopoulou, A., He, Y., Montezano, A. C. I., Jaisser, F., et al. (2016) · Diabetes · doi:10.2337/db15-1627 · Cited by 62
Self-citationMichalak, A., Mosińska, P., & Fichna, J. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.04.016 · Cited by 63
Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease
Huston, J., & Shah, S. J. (2022) · Circulation Research · doi:10.1161/circresaha.122.319967 · Cited by 61
Aldosterone Production and Signaling Dysregulation in Obesity
Vecchiola, A., Lagos, C. F., Carvajal, C. A., Baudrand, R. F., & Fardella, C. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0626-9 · Cited by 61
Packer, M. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1167 · Cited by 61
From Obesity to Chronic Kidney Disease: How Can Adipose Tissue Affect Renal Function?
Martín-Taboada, M., Vila‐Bedmar, R., & Medina‐Gómez, G. (2021) · The Nephron journals/Nephron journals · doi:10.1159/000515418 · Cited by 60
Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone
Muñoz‐Durango, N., Vecchiola, A., González-Gómez, L. M., Simón, F., Riedel, C. A., Fardella, C., & Kalergis, A. M. (2015) · BioMed Research International · doi:10.1155/2015/652738 · Cited by 60
Friederich‐Persson, M., Cat, A. N. D., Persson, P., Montezano, A. C. I., & Touyz, R. M. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308659 · Cited by 58
Self-citationAbnormal Aldosterone Physiology and Cardiometabolic Risk Factors
Vaidya, A., UNDERWOOD, P. C., Hopkins, P. N., Jeunemaı̂tre, X., Ferri, C., Williams, G. H., & Adler, G. K. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00662 · Cited by 58
Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension
Dudenbostel, T., Ghazi, L., Liu, M., Li, P., Oparil, S., & Calhoun, D. A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07806 · Cited by 58
Feraco, A., Armani, A., Mammi, C., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.012 · Cited by 58
Lastra, G., & Sowers, J. R. (2013) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0025 · Cited by 55
Bruder-Nascimento, T. B., Silva, M. A. B., & Tostes, R. C. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-90 · Cited by 54
Queiroz, M., & Sena, C. M. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02549-9 · Cited by 53
The multifaceted mineralocorticoid receptor
Gomez‐Sanchez, E., & Gomez‐Sanchez, C. E. (2014) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2014.tb00569.x · Cited by 55
Zheng, X., Han, L., & Shen, S. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003259 · Cited by 52
Impact of Adrenal Steroids on Regulation of Adipose Tissue
Infante, M., Armani, A., Mammi, C., Fabbri, A., & Caprio, M. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160037 · Cited by 58
Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study
Joseph, J. J., Echouffo-Tcheugui, J. B., Kalyani, R. R., Yeh, H.-C., Bertoni, A. G., Effoe, V. S., Casanova, R., Sims, M., Correa, A., Wu, W.-C., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1002 · Cited by 51
Use of Aldosterone Antagonists for Treatment of Uncontrolled Resistant Hypertension
Dudenbostel, T., & Calhoun, D. A. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpw105 · Cited by 51
Metabolic Syndrome: The Constellation of Co-morbidities, A Global Threat
Madan, K., Paliwal, S., Sharma, S. K., Kesar, S., Chauhan, N., & Madan, M. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230309144825 · Cited by 55
Dorresteijn, J. A. N., Schrover, I. M., Visseren, F. L. J., Scheffer, P. G., Oey, P. L., Danser, A. H. (., & Spiering, W. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835b6c02 · Cited by 50
Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction
Butt, J. H., Henderson, A. D., Jhund, P. S., Claggett, B. L., Desai, A. S., Lay‐Flurrie, J., Viswanathan, P., Lage, A. Z., Scheerer, M. F., Lam, C. S. P., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.10.111 · Cited by 55
Bruder-Nascimento, T. B., Callera, G. E., Montezano, A. C. I., He, Y., Antunes, T. T., Cat, A. N. D., Tostes, R. C., & Touyz, R. M. (2014) · Clinical Science · doi:10.1042/cs20140456 · Cited by 49
Self-citationMartin, R. E., Aebi, J. D., Hornsperger, B., Krebs, H.-J., Kuhn, B., Kuglstatter, A., Alker, A., Märki, H. P., Müller, S. G., Burger, D., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00851 · Cited by 50
Self-citation
Metadata
- Authors
- Briones, A. M., Nguyen Dinh Cat, A., Callera, G. E., Yogi, A., Burger, D., He, Y., Corrêa, J. W., Gagnon, A. M., Gomez-Sanchez, C. E., Gomez-Sanchez, E. P., Sorisky, A., Ooi, T. C., Ruzicka, M., Burns, K. D., & Touyz, R. M.
- Affiliations
- University of Ottawa (CA)
- From the Kidney Research Centre (A.M.B., A.N.D.C., G.E.C., A.Y., D.B., Y.H., J.W.C., K.D.B., R.M.T.), Chronic Disease Program (A.M.G., A.S., T.C.O.), Ottawa Hospital Research Institute, and Division of Nephrology, Department of Medicine (M.R.), University of Ottawa, Ontario, Canada; G.V. (Sonny) Montgomery Veterans Affairs and Division of Endocrinology, Department of Medicine, University of Mississippi Medical Centers, Jackson, MS (C.E.G.-S., E.P.G.-S.); Current address (A.M.B.): Departamento...
- ORCID
- Venue
- Hypertension
- Published
- 2012-05
- Volume
- 59
- Issue
- 5
- Pages
- 1069-1078
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2111017518
- Cited by
- 375
- References
- 39
- Citations by year
- 2026: 24 · 2025: 29 · 2024: 26 · 2023: 30 · 2022: 18 · 2021: 28 · 2020: 22 · 2019: 19 · 2018: 27 · 2017: 21 · 2016: 27 · 2015: 35 · 2014: 32 · 2013: 27 · 2012: 10
- FWCI
- 26.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- aldosterone synthase, calcineurin, NFAT, angiotensin II, angiotensin II type 1 receptor, adipogenesis, vascular dysfunction, db/db mice, perivascular adipose tissue, mesenteric arteries, acetylcholine-induced relaxation, mineralocorticoid receptor, candesartan, eplerenone, autocrine and paracrine signaling
- MeSH terms
- Aldosterone, Animals, Benzimidazoles, Biphenyl Compounds, Cells, Cultured, Diabetic Angiopathies, Disease Models, Animal, Humans, Mice, Inbred C57BL, Obesity, Random Allocation, Sensitivity and Specificity, Tetrazoles, Signal Transduction, Adipocytes, Calcineurin, Diabetes Complications, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review